Horizon Bancorp Inc /In/ Gilead Sciences, Inc. Transaction History

Horizon Bancorp Inc /In/

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $283,244 - $406,641	-4,545 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $22,790 - $28,655	367 Added 8.78%	4,545 $287,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $77,765 - $90,300	-1,075 Reduced 20.46%	4,178 $321,000
Q1 2020 Apr 20, 2020	SELL	$62.63 - $80.22 $21,106 - $27,034	-337 Reduced 6.03%	5,253 $393,000
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $344,455 - $378,890	5,590 New	5,590 $363,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Horizon Bancorp Inc /In/, based on Form 13F filings with the SEC.

Stay updated on Horizon Bancorp Inc /In/ with notifications on news.